2010
DOI: 10.1097/pec.0b013e3181e057e1
|View full text |Cite
|
Sign up to set email alerts
|

Off-Label and Unlicensed Medication Use and Associated Adverse Drug Events in a Pediatric Emergency Department

Abstract: The frequency of reported ADEs associated with OL/UL medications was less than the frequency of ADEs from licensed medication use, with overall ADE frequency of less than 1%.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
27
2
2

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(35 citation statements)
references
References 22 publications
4
27
2
2
Order By: Relevance
“…This concurred with a recent study conducted in the US where inhaled bronchodialators (30.4%) and antimicrobials (14.8%) were the most commonly prescribed unlicensed/off-label medication classes in a paediatric emergency department [24]. In the present study, however, antibiotic use (44% of total medications) was high compared to other reports from similar studies in other countries [25][26][27].…”
Section: Discussionsupporting
confidence: 93%
“…This concurred with a recent study conducted in the US where inhaled bronchodialators (30.4%) and antimicrobials (14.8%) were the most commonly prescribed unlicensed/off-label medication classes in a paediatric emergency department [24]. In the present study, however, antibiotic use (44% of total medications) was high compared to other reports from similar studies in other countries [25][26][27].…”
Section: Discussionsupporting
confidence: 93%
“…Those studies that have been performed in pediatric patients have used retrospective design or significantly limited prospective methodologies, which preclude accurate determination of the magnitude of this issue. 16,[45][46][47][48][49][50][51][52][53][54][55] Retrospective evaluation, often conducted by using medical record review or use of administrative databases, has inherent limitation for reporting bias, challenges with event ascertainment, as well as causality and preventability assessment, and has reported much lower event rates compared with prospective studies. 11,56 Finally, no study has prospectively explored this issue in Canada, so the impact in our own country remains uncertain.…”
Section: What This Study Addsmentioning
confidence: 99%
“…Most of the previously published studies on off-label prescriptions typically only described the extent of offlabel drug use [5][6][7], and few conducted an evaluation of supporting evidence. Furthermore, only the DRUGDEX system was used when searching for supporting evidence [8].…”
Section: Introductionmentioning
confidence: 99%